1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Rise in the Incidences of Cardiovascular Diseases 6.1.2 Investments in R&D of Heart Disease Detection 6.1.3 Ease and Use of Portability in Devices 6.1.4 Demand for Home-based, Point-of-care, and Remote Monitoring Cardiac Systems 6.2 Market Restraints 6.2.1 Risk of Infection, due to Implantable Monitoring Devices 6.2.2 Low Level of Accuracy with Invasive Cardiac Output Monitoring Devices 6.3 Stringent FDA and Validator Regulations 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Device Type 7.1.1 Insertable Cardiac Monitoring Devices 7.1.2 Cardiac Output Monitoring Devices 7.1.3 Electrocardiogram 7.1.4 Cardiac Event Monitoring Systems 7.1.5 Others 7.2 Segmentation - by Geography 7.2.1 Europe 7.2.1.2 France 7.2.1.2 Germany 7.2.1.3 United Kingdom 7.2.1.4 Italy 7.2.1.5 Spain 7.2.1.6 Rest of Europe 8. Competitive Landscape 8.1 Mergers and Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Product Launches 9. Key Players 9.1 Abbott 9.2 Applied Cardiac Systems 9.3 Boston Scientific 9.1 Cardiac Science Corporation 9.2 GE Healthcare 9.6 LifeWatch AG 9.3 Medtronic 9.4 Mennen Medical 9.5 Phillips Healthcare 9.10 Schiller Americas Inc. 9.6 Siemens Healthcare 9.7 Roche Diagnostics 9.8 Canon Medical Systems Corporation 9.9 Welch Allyn 9.10 Others 10. Future of the Market

Cardiac Science Corporation, Ge Healthcare, Medtronic Plc, Mennen Medical, Phillips Healthcare, Siemens AG, Roche Diagnostics, Canon Medical Systems Corporation, Welch Allyn